The Chosun Ilbo on MSN
GLP-1 obesity drugs may reduce addiction risks, study finds
A study has found that GLP-1 class obesity treatments, such as Wegovy and Mounjaro, may reduce the risk of alcohol or ...
A class-action lawsuit has been filed against CVS Caremark over its decision to stop covering Zepbound, Eli Lilly’s blockbuster GLP-1 drug to treat obesity. When the major pharmacy benefit manager ...
WHO guidelines conditionally endorse long-term GLP-1 therapy for obesity, emphasizing lifestyle modifications and addressing affordability and access challenges. GLP-1 therapies are included in the ...
LONDON, UNITED KINGDOM - OCTOBER 8: A photo illustration of a mounjaro injection pen and some weight scales on October 8, 2025 in London, United Kingdom. (Photo by Peter Dazeley/Getty Images) The ...
The last time I wrote about Terns Pharmaceuticals (TERN), it was with respect to a Seeking Alpha article entitled "Terns Pharmaceuticals: Obesity Advancement Continues With Other Q1 2025 Program ...
(CNN) — A class-action lawsuit has been filed against CVS Caremark over its decision to stop covering Zepbound, Eli Lilly’s blockbuster GLP-1 drug to treat obesity. (CNN) — A class-action lawsuit has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results